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Hair cosmetic agents are preparations intended for placing in contact with the hair and scalp, with the purpose of
cleansing, promoting attractiveness, altering appearance, and/or protecting them in order to maintain them in good
condition. Current shampoo formulations and styling products are tailored to the variations associated with age,
gender, hair quality, hair care habit, and specific problems relating to the superﬁcial condition of the scalp. The
great amount of variables to be accounted for, some of them contradictory and hard to bring into accord, makes
adequate product formulation a challenge and requires continuous research. Recent hair cosmetic developments
include topical hair growth stimulants, photoprotectors, and anti-aging compounds. The advances in molecular
technology have opened the avenue to the study of the molecular basis of hair growth and its deviations, as well as
of the aging process. The discovery of potential pharmacological targets and the development of selective and
effective delivery systems following topical application indicate further strategies for maintenance of healthy hair
and scalp in the young and old.
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Hair cosmetic agents are preparations intended for placing
in contact with the hair and scalp, with the purpose of
cleansing, promoting attractiveness, altering appearance,
and/or protecting them in order to maintain them in good
condition. Although shampooing has been the most com-
mon form of cosmetic hair treatment, primarily aimed at
cleansing the hair and scalp, the present-day consumer
expects more options. The cosmetic industry has become
aware of this, and has become more capable of delivering
active dermocosmetic agents that are directed toward
meeting this consumer demand.
Clinical Approach to Common Hair and
Scalp Complaints
Antonella Tosti reviewed conditions underlying common hair
and scalp complaints, such as hair weathering, dandruff,
itchy scalp, greasy scalp, and the ‘‘red scalp syndrome,’’
and further characterized them on the basis of video-
dermoscopy findings. Epiluminiscence microscopy of the
scalp at  10 magnification reveals pathologic conditions
of the hair shaft and scalp not readily recognized by the
naked eye. Examples are hair diameter diversity, the ‘‘per-
ipilar signs’’ (PPS) around the hair ostia and vascular ab-
normalities (teleangiectasia) of the scalp.
Hair diameter diversity has been identified as a marker
for the hair follicle miniaturization process in the course of
androgenetic alopecia (de Lacharrie`re et al, 2001).
A correlation of PSS with histological findings has re-
vealed that the presence of PPS could reflect the presence
of perifollicular inflammatory infiltrates and fibrosis (Deloche
et al, 2004). The implication of microscopic follicular in-
flammation in the pathogenesis of androgenetic alopeica
(AGA) has emerged from several independent studies (Jaw-
orsky et al, 1992; Whiting, 1993; Mahe´ et al, 2000). The term
‘‘microinflammation’’ has been proposed, because the
process involves a slow, subtle, and indolent course, in
contrast to the inflammatory and destructive process in
the classical inflammatory scarring alopecias (Mahe´ et al,
2000). An important question is how the inflammatory
reaction pattern is generated around the individual hair
follicle. The localization in the upper follicle near the in-
fundibulum suggests that the primary causal event for the
triggering of inflammation might occur at this site. Consid-
ering the microbial colonization of the follicular in-
fundibulum, one could speculate that microbial toxins or
antigens may be involved in the generation of the inflam-
matory response. Alternatively, keratinocytes themselves
may respond to chemical stress from irritants, pollutants,
and ultraviolet (UV) irradiation, by producing radical oxygen
species, nitric oxide, and releasing pro-inflammatory
cytokines. In the case where the causal agents persist,
sustained inflammation occurs, together with connective
tissue remodeling, where collagenases play a role. Colla-
genases are suspected to contribute to the tissue changes
in perifollicular fibrosis. Finally, permanent hair loss results
form irreversible damage to the putative site of follicular
stem cells in the ‘‘bulge’’ area of the outer-root sheath in the
superficial portion of the hair follicle (Lavker et al, 1993). The
preference of this site for the immunologic attack may
be related to the fact that, in contrast to the proximal hairAbbreviation: UV, ultraviolet
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follicle, the isthmus, and infundibulum area do not bear any
immune privilege (Paus, 1997).
The ‘‘red scalp syndrome’’ is an ill-defined condition,
characterized by persistent erythema of the scalp that is not
otherwise explained through a specific dermatologic con-
dition, such as seborrhoic dermatitis. First described by
Thestrup-Pedersen and Hjorth (1987), it has been com-
mented upon in the English language by Moschella (1994),
who stated the problem of ‘‘diffuse red scalp disease which
can also be itchy and burning. Clinically, there is no scaling,
no hair loss, and no scarring. It is non responsive to any
therapy including potent topical steroids or anti-seborrhoic
therapy.’’ A study of 18 patients with ‘‘red scalp syndrome’’
showed that the scalp redness was associated with AGA in
the majority of patients.1 Patients often report associated
discomfort of the scalp (trichodynia). In another series of
patients complaining of hair loss and trichodynia, the de-
rmatoscopic finding of scalp telangiectasia was found to
strongly correlate with the presence of trichodynia (Willi-
mann and Tru¨eb, 2002). An interesting analogy to rosacea
exists, in which it was found that patients with the tel-
angiectatic variant respond more frequently with astinging
sensation to the topical application of 5% lactic acid on the
cheek than patients with the papulopustular type of rosacea
or normal controls (Lonne-Rahm et al, 1999). In patients
with trichodynia, overexpression of neuropeptide substance
P has been found (Ericson et al, 1999), suggesting a con-
nection between sensory or subjective irritation and cuta-
neous vascular reactivity.
Dermocosmetic Management in Practice for
the Maintenance of Healthy Hair and Scalp
Ralph Tru¨eb reviewed cosmetic hair treatments and de-
rmocosmetic treatments for dandruff, greasy hair, scalp
itch, and hair loss. Although shampoos have primarily been
products aimed at cleansing the hair and scalp, the diversity
of qualities demanded by the present-day consumer go well
beyond this function. Current shampoo formulations are
adapted to the variations associated with hair quality, hair
care habit, and specific problems related to the superficial
condition of the scalp (Bouillon, 1996; Shapiro and Maddin,
1996; Tru¨eb, 2001). Accordingly, a shampoo is composed of
up to 30 different ingredients: cleansing agents, additives,
conditioning agents, and special care ingredients.
Cleansing agents function by weakening the physico-
chemical adhesive force that binds soil to hair, taking it up
and transferring it into the aqueous rinse, and dispersing it
and preventing redeposition on the hair fiber. This action is
carried out by surfactants, compounds with dual affinity:
they are both lipophilic by their hydrocarbon fatty chain,
which bonds to greasy soil, and hydrophilic by the polar
head group at the end of the fatty chain, which makes them
water soluble. Depending on the charge of the polar head
group, surfactants are divided into anionics, cationics,
amphoterics, and non-ionics. A shampoo comprises a
mixture of several surfactants, as a single surfactant can-
not adequately ensure all expected cosmetic benefits. Al-
though anionics are the primary-cleansing agents,
cationics, amphoterics, and non-ionics are utilized to mod-
ify surfactant activity. By virtue of their positive charge, cat-
ionics show high affinity for hair fiber that is negatively
charged. They impart softness to the hair and ease of
combing and reducing flyaway, making them appropriate
for the care of weathered hair. Amphoterics form a complex
with anionics, reducing the latter’s tendency to adsorb onto
proteins. Generally combined with other surfactants in the
formulation of mild shampoos, they modulate cleansing ef-
ficiency and enhance lathering qualities. Finally, non-ionics
are the mildest of all surfactants. Their high level of toler-
ance by the skin has found application in their combination
with anionics or amphoterics for very mild shampoos.
Additives that contribute to the stability and comfort of
the product include foam stabilizers, thickeners, chelating
agents, preservatives, pearlescents, opacifiers, fragrances,
and colorants.
Conditioning agents are intended to impart softness and
gloss, to reduce flyaway, and to enhance disentangling fa-
cility. They are particularly beneficial for the care of dry hair
and weathered hair. A number of ingredients may be intro-
duced into shampoos, mostly fatty ingredients, hydrolyzed
proteins, quaternized cationic derivatives, cationic poly-
mers, and more recently, silicones. By the virtue of their high
spreading coefficients, silicones, such as dimethicone,
readily spread over the surface of hair forming a thin, uni-
form, hydrophobic film that increases luster and gloss. The
lubricant nature of the film reduces inter-fiber friction, re-
sulting in less need for combing force and thus less damage
during grooming.
Finally, special care ingredients are aimed at modifying
specific problems relating to the superficial condition of the
scalp. They include anti-dandruff agents, humefactants,
and anti-pruritic agents.
The great amount of variables to be accounted for, some
of them contradictory and hard to bring into accord, makes
adequate product formulation a challenge and requires
continuous research, as is reflected by the large number of
patents appearing in this field. Constant research to find
new formulas is at the root of the progress of shampoo
technology. For example, micronization of the anti-dandruff
agent zink pyrithione has enhanced its efficacy with shorter
contact time. Altogether, test methods have been devel-
oped to evaluate the efficacy of hair care products, so con-
sumers are offered reliable products that perform as
claimed. This has been achieved by transferring consum-
ers’ perceived attributes into scientifically measurable qual-
ities and correlating these laboratory data with real-life
results.
Recent dermocosmetic developments include topical
hair growth stimulants, photoprotectors of hair and scalp,
and anti-aging compounds.
The rational basis for the development of topical hair
growth stimulants are: effect on androgen metabolism
(Kaufman, 1996), effect on sebum production and microbi-
al flora (Pierard et al, 1996), effect on microinflammation and
fibrosis (Whiting, 1993), and effect on vascularization and
vascular epidermal growth factor (Lachgar et al, 1998).
1Grimalt R, Lacueva L, Hasmann G, Ferrando J. Red scalp
syndrome. Annual Meeting of the European Hair Research Society
(EHRS), Barcelona, 2000 Abstract F11: 22, 2000.
290 TRU¨EB JID SYMPOSIUM PROCEEDINGS
Among topical hair growth stimulants, minoxidil is the drug
with proven efficacy. It has become mandatory that the ef-
ficacy of a dermocosmetic agent that claims to act as a hair
growth stimulant is measured by the scientific standards set
by the clinical studies performed with topical minoxidil and,
more recently, oral finasteride for treatment of AGA (Price,
1999). Certainly, hair growth stimulants incorporated into
shampoos do not have any impact on hair growth because
of short contact time and water dilution. Alternatively, the
mechanics of taking care of thinned hair are underrated: the
first thing to recommend is to shampoo hair frequently with
an appropriate shampoo that will leave the hair fluffy and
give the illusion of thicker hair.
Aging affects the hair follicle with a decrease of me-
lanocyte function and of hair production (Tobin and Paus,
2001; van Neste and Tobin, 2004). The scalp is subject to
both intrinsic or physiologic aging, and extrinsic aging be-
cause of external factors. Intrinsic factors are related to in-
dividual genetic and epigenetic mechanisms with inter-
individual variations. Prototypes are AGA (Tru¨eb, 2002), and
familial premature graying. Extrinsic factors include UVR
(Tru¨eb, 2003b), pollution, smoking (Tru¨eb, 2003a), nutrition,
and lifestyle. Experimental evidence supports the hypoth-
esis that oxidative stress plays a role in premature aging.
Besides hair conditioners and humefactants for the care of
the hair shaft, topical anti-aging compounds would thus in-
clude photoprotectors and antioxidants. Others of interest
are green tea polyphenols, phytoestrogens, melatonin
(Bangha et al, 1996; Fischer et al, 2001), and as yet un-
identified substances from TCM and Ayurveda. With re-
spect to photoprotection, hair dyes provide protection of
the hair shaft (Pande et al, 2001), and topically applied
chemicals that act as UV protectors are under research.
Cinnamidpropyltrimonium chloride, a quaternized UV ab-
sorber delivered in shampoos, has both UV protective and
conditional benefits (Gao and Bedell, 2001). Solid lipid
nanoparticles as carriers of UV blockers are under current
investigation (Wissing and Muller, 2001). Antioxidants, such
as ascorbic acid and tocopherol acetate, protect fatty
shampoo ingredients, but not the scalp and hair from ox-
idation.
Research Activities, Innovations, and Future
Outlooks in Hair Care
Bruno Bernard gave an overview of current research activ-
ities and innovation in hair care, as well as future outlooks in
hair research. Current research activities are focused at
deciphering the molecular mechanisms involved in the con-
trol of the different phases of the hair cycle, and the tran-
sition from one phase to another. To date, progress has
been achieved in the understanding of the signals involved
in the primary organogenesis of the hair follicle. It is not
certain, however, whether it may give clues to manipulate
telogen–anagen transition. The localization of putative stem
cells in the ‘‘bulge’’ area of the outer-root sheath in the su-
perficial portion of the hair follicle (Cotsarelis et al, 1990)
from where the follicle is cyclically renewed is also actively
ongoing with the identification of specific markers, future
tools to isolate and manipulate these cells. Meanwhile,
molecular characterization of the hair follicle compartments
has still not been completely achieved, and subtle sub-
compartmentalization of basal membrane, connective tis-
sue sheath versus dermal papilla, outer hair root sheath,
inner hair root sheath, and hair fiber is being revealed. The
complexity of the hair follicle composition probably explains
the paucity of recognized active molecules at controlling
hair growth and hair cycling, and new avenues are being
investigated, i.e., through genomics and proteomics. Even
though considerable data will be generated, however, it will
probably take a while before pertinent information will be
extracted from them. Moreover, as the immediate vascular,
nervous, and dermal environment of the hair follicle also
plays a very likely major role in its biology, it will have to be
taken into consideration more thoroughly.
Furthermore, hair pigmentation and the graying process
are thoroughly being studied, and new insights are being
obtained with respect to the role of absolute melanocyte
number, and the melanogenesis pathway that operates in
the hair follicle melanocyte (Commo et al, 2004). Although
graying is understood as a loss of pigment in the shaft, its
cellular and molecular origins are incompletely understood
(Tobin and Paus, 2001; van Neste and Tobin, 2004). The
color of hair mainly relies on the presence or absence of
melanin pigment. Melanin is formed in melanosomes, pro-
duced by melanocytes, and is the product of a complex
biochemical pathway (melanogenesis), with tyrosinase be-
ing the rate-limiting enzyme. It has been shown that gray
hair has undergone a marked reduction in melanogenically
active melanocytes in the hair follicle (Commo et al, 2004).
The net effect of this reduction is that fewer melanosomes
are incorporated into cortical keratinocytes. In addition,
there appears to be a defect of melanosome transfer. This
defect is further corroborated by the observation of melanin
debris in and around the graying hair bulb. This anomaly is
because of either defective melanosomal transfer to cortical
keratinocytes or melanin incontinence from melanocyte de-
generation. Eventually, no melanogenic melanocytes remain
in the hair bulb. This decrease of melanin synthesis is as-
sociated with a decrease in tyrosinase activity. Ultrastruc-
tural studies have shown that the remaining melanocytes
not only contain fewer melanosomes, but the residual
melanosomes may be packaged within autophagolyso-
somes. This removal of melanosomes into autophagolyso-
somes suggests that they are defective, possibly with
reactive melanin metabolites. This interpretation is support-
ed by the observation that melanocytes in graying hair bulbs
are frequently highly vacuolated, a common cellular re-
sponse to increased oxidative stress. The extraordinary
melanogenic activity of pigmented bulbar melanocytes,
continuing for up to 10 y in some hair follicles, is likely to
generate large amounts of reactive oxygen species via the
hydroxylation of tyrosine and the oxidation of DOPA to
melanin. If not adequately removed by efficient antioxidant
system, an accumulation of these reactive oxidative species
will generate significant oxidative stress. It is possible that
the antioxidant system may become impaired with age,
leading to damage to the melanocyte itself from its own
melanogenesis-related oxidative stress. As mutations occur
at a higher rate in tissue exposed to high levels of oxidative
stress, and these accumulate with age, the induction of
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replicative senescence is likely to be an important protec-
tive mechanism against cell transformation.
Finally, there is an increasing interest in the hair follicular
route for delivery of active compounds affecting the hair.
Current research activities focus on topical liposome tar-
geting for melanins, genes, and proteins selectively to hair
follicles for therapeutic and cosmetic modification of hair
(Hoffman, 1998). For example, topical liposome selective
delivery to hair follicles has demonstrated the ability to color
hair with melanin. The discovery of potential targets and the
development of both selective and effective delivery sys-
tems following topical application (Li and Hoffman, 1995)
indicate further rational strategies for maintenance of
healthy hair and scalp in the young and old.
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